Systematic profiling of SARS-CoV-2-specific IgG epitopes at amino acid resolution
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.09.08.20190496: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Serum collection: This study was approved by the Institutional Ethics Review Committee of Foshan Fourth Hospital, Foshan, China.
Consent: The written informed consent was obtained from each patient.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources The samples, i. e., 1 µL for serum sample or α-His antibody and 400 ng for proteins enriched antibodies, were added per well. α-Hissuggested: NoneSoftware and Algorithms Sentences Resources All the structural analyses were processed by using Pymol. Pymolsuggested: (PyMOL, RRID:SCR_000305)All the Signal … SciScore for 10.1101/2020.09.08.20190496: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Serum collection: This study was approved by the Institutional Ethics Review Committee of Foshan Fourth Hospital, Foshan, China.
Consent: The written informed consent was obtained from each patient.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources The samples, i. e., 1 µL for serum sample or α-His antibody and 400 ng for proteins enriched antibodies, were added per well. α-Hissuggested: NoneSoftware and Algorithms Sentences Resources All the structural analyses were processed by using Pymol. Pymolsuggested: (PyMOL, RRID:SCR_000305)All the Signal intensities were analyzed by the software GraphPad Prism version 7.0. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-